Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 3
2000 4
2002 3
2003 7
2004 5
2005 5
2006 2
2007 6
2008 8
2009 11
2010 10
2011 4
2012 4
2013 4
2014 8
2015 10
2016 10
2017 2
2018 11
2019 10
2020 9
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30005760

128 results

Results by year

Filters applied: . Clear all
Page 1
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; Pasireotide C2402 Study Group. Gadelha MR, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):875-84. doi: 10.1016/S2213-8587(14)70169-X. Epub 2014 Sep 24. Lancet Diabetes Endocrinol. 2014. PMID: 25260838 Clinical Trial.
The German ACROSTUDY: past and present.
Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Strasburger CJ; German Pegvisomant Observational Study. Buchfelder M, et al. Eur J Endocrinol. 2009 Nov;161 Suppl 1:S3-S10. doi: 10.1530/EJE-09-0350. Epub 2009 Aug 14. Eur J Endocrinol. 2009. PMID: 19684061
128 results